We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
On this mini-podcast, we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
